ProPhase Labs Inc (NASDAQ:PRPH) is pursuing a $50 million cash recovery from COVID-19 receivables through Crown Medical Collections, which could significantly boost the company's market cap. The ...
Hosted on MSN
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances
Ted Karkus, Chairman & CEO, opened by emphasizing the critical importance of shareholder voting on the company's proxy, noting, "If you do not vote for our proxy, you are putting our company in harm's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback